Pall Corp. will acquire the ATMI LifeSciences business of ATMI, Inc. for $185 million. ATMI LifeSciences makes and sells single-use bioprocess systems and consumables for the pharma and biopharma industries. The deal is expected to close by the end of Pall’s third quarter, which ends in April 2014. For the balance of fiscal 2014, Pall expects the acquisition to add $20 to $30 million in revenue.
“This acquisition immediately strengthens our offering and broadens our already extensive portfolio of advanced solutions for biopharmaceutical customers,” said Larry Kingsley, Pall’s chairman and chief executive officer.
Doug Neugold, ATMI’s chief executive officer, said, “We are very happy to have Pall as the new owner of this business, and believe the fit and their capabilities will accelerate its growth and provide great support to our customers.”